Clinical Trial Update: An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications [Phase 3]

View source ↗

Summary

Extension study assessing safety, tolerability, and efficacy of ABT-SLV187 in advanced Parkinson's disease with persistent motor complications after optimized a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ABT-SLV187

Snippet

Sponsor: AbbVie | Conditions: Advanced Parkinson's Disease | Phase 3 | Status: COMPLETED